Table 1.
Cohort characteristics
| Total | SCC | CHH | RJH | |
|---|---|---|---|---|
| Age, n (%) | ||||
| <60 | 946 (52.9) | 517 (52.8) | 289 (51.2) | 140 (57.4) |
| ≥60 | 841 (47.1) | 462 (47.2) | 275 (48.8) | 104 (42.6) |
| Sex, n (%) | ||||
| Male | 1135 (63.5) | 630 (64.4) | 349 (61.9) | 156 (63.9) |
| Female | 652 (36.5) | 349 (35.6) | 215 (38.1) | 88 (36.1) |
| Smoking, n (%) | ||||
| Yes | 849 (47.9) | 489 (50.4) | 250 (44.6) | 110 (45.3) |
| No | 925 (52.1) | 482 (49.6) | 310 (55.4) | 133 (54.7) |
| Alcohol, n (%) | ||||
| Yes | 242 (13.6) | 142 (14.5) | 66 (11.8) | 34 (14.0) |
| No | 1535 (86.4) | 835 (85.5) | 492 (88.2) | 208 (86.0) |
| Stage, n (%) | ||||
| Stage III | 707 (39.6) | 362 (37.0) | 243 (43.1) | 102 (41.8) |
| Stage IV | 1080 (60.4) | 617 (63.0) | 321 (56.9) | 142 (58.2) |
| Primary tumor location, n (%) | ||||
| Head and neck | 762 (42.6) | 408 (41.7) | 262 (46.5) | 92 (37.7) |
| Body and tail | 1025 (57.4) | 571 (58.3) | 302 (53.5) | 152 (62.3) |
| Primary tumor diameter, n (%) | ||||
| <20 mm | 280 (15.7) | 172 (17.6) | 76 (13.5) | 32 (13.1) |
| ≥20 mm | 1507 (84.3) | 807 (82.4) | 488 (86.5) | 212 (86.9) |
| ALT or AST, n (%) | ||||
| Normal | 1495 (83.7) | 813 (83.0) | 476 (84.4) | 206 (84.4) |
| Elevated | 292 (16.3) | 166 (17.0) | 88 (15.6) | 38 (15.6) |
| ALB, n (%) | ||||
| Normal | 1377 (77.1) | 759 (77.5) | 428 (75.9) | 190 (77.9) |
| Low | 410 (22.9) | 220 (22.5) | 136 (24.1) | 54 (22.1) |
| CA19-9, n (%) | ||||
| Normal | 371 (20.8) | 214 (21.9) | 106 (18.8) | 51 (20.9) |
| Elevated | 1416 (79.2) | 765 (78.1) | 458 (81.2) | 193 (79.1) |
SCC Shanghai Cancer Center, CHH ChangHai Hospital, RJH RuiJin Hospital